Adjuvant immune checkpoint inhibitor therapy after curative-intent resection or ablation for high-risk hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Oncology
Published
2026-05-28
DOI
https://doi.org/10.1200/jco.2026.44.16_suppl.e16289
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Adjuvant immune checkpoint inhibitor therapy after curative-intent resection or ablation for high-risk hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials.

A Eftaiha, Sakshi Singal, Hasan Daher, Saba Daher et al.
Journal of Clinical Oncology
Hepatocellular Carcinoma Treatment and Prognosis
article

Adjuvant immune checkpoint inhibitor therapy after curative-intent resection or ablation for high-risk hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials.

A Eftaiha, Sakshi Singal, Hasan Daher, Saba Daher, Hamza Altal, Ban Al-Goran
article en

Abstract

No abstract available for this paper.
Journal of Clinical OncologyVol. 44(16_suppl)
East Tennessee State University (US), Jordan University of Science and Technology (JO)
No poverty
Openalex Percentile: Top 7%
Hepatocellular Carcinoma Treatment and Prognosis
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Adjuvant immune checkpoint inhibitor therapy after curative-intent resection or ablation for high-risk hepatocellular carcinoma: A systematic review and meta-analysis of randomized controlled trials. — A Eftaiha, Sakshi Singal, et al. · Journal of Clinical Oncology (2026) | TGRS Research Map | TGRS